- Home
- GLYC vs SISI Comparison
GLYC vs SISI Comparison
Compare GLYC & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLYC
- SISI
- Stock Information
- Founded
- GLYC 2003
- SISI 1997
- Country
- GLYC United States
- SISI China
- Employees
- GLYC N/A
- SISI N/A
- Industry
- GLYC Biotechnology: Pharmaceutical Preparations
- SISI Medicinal Chemicals and Botanical Products
- Sector
- GLYC Health Care
- SISI Health Care
- Exchange
- GLYC Nasdaq
- SISI Nasdaq
- Market Cap
- GLYC 15.9M
- SISI 17.9M
- IPO Year
- GLYC 2014
- SISI 2016
- Fundamental
- Price
- GLYC $0.19
- SISI $0.88
- Analyst Decision
- GLYC Hold
- SISI
- Analyst Count
- GLYC 3
- SISI 0
- Target Price
- GLYC N/A
- SISI N/A
- AVG Volume (30 Days)
- GLYC 228.8K
- SISI 128.8K
- Earning Date
- GLYC 05-08-2025
- SISI 05-14-2025
- Dividend Yield
- GLYC N/A
- SISI N/A
- EPS Growth
- GLYC N/A
- SISI N/A
- EPS
- GLYC N/A
- SISI N/A
- Revenue
- GLYC N/A
- SISI $11,072,553.00
- Revenue This Year
- GLYC N/A
- SISI N/A
- Revenue Next Year
- GLYC N/A
- SISI N/A
- P/E Ratio
- GLYC N/A
- SISI N/A
- Revenue Growth
- GLYC N/A
- SISI 145.88
- 52 Week Low
- GLYC $0.14
- SISI $0.73
- 52 Week High
- GLYC $3.02
- SISI $117.65
- Technical
- Relative Strength Index (RSI)
- GLYC 31.68
- SISI 42.72
- Support Level
- GLYC $0.19
- SISI $0.85
- Resistance Level
- GLYC $0.22
- SISI $1.27
- Average True Range (ATR)
- GLYC 0.02
- SISI 0.15
- MACD
- GLYC -0.01
- SISI 0.01
- Stochastic Oscillator
- GLYC 16.67
- SISI 22.37
About GLYC GlycoMimetics Inc.
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.